All persons or entities that purchased or otherwise acquired the publicly-traded common stock of Acer Therapeutics Inc. (“Acer” or the “Company”) during the period between September 25, 2017 and June 24, 2019, both dates inclusive.
Disbursed
September 24, 2017 - September 20, 2019
January 07, 2022
December 17, 2021
Strategic Claims Services
Acer Therapeutics Inc. Securities Litigation c/o Strategic Claims Services 600 N. Jackson St., Ste. 205 P.O. Box 230 Media, PA 19063
+1 866-274-4004
info@strategicclaims.net
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.